CUBIST PHARMACEUTICALS $49.51

up +0.88


17/5/2013 05:17 PM  |  NASDAQ : CBST  |  Industries : Manufacturing / Pharmaceutical and Medicine Manufacturing
12 Mo. Price Change : 18% - CBST has underperformed the S&P 500 by 8%

Get Trend Analysis Icon Get Trend Analysis

Partner Headlines

  1. Magic Formula Formulator Joel Greenblatt's Top 5 New Stock Picks

    GuruFocus

  2. UPDATE: Aegis Capital Initiates Coverage on Cubist Pharmaceuticals ...

    Benzinga

  3. Cubist Pharmaceuticals, Inc. (CBST) President & CEO Michael W ...

    GuruFocus

  4. UPDATE: Cantor Fitzgerald Upgrades Cubist Pharmaceuticals to Hold; ...

    Benzinga

  5. Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry With ...

    Benzinga

  6. Cubist Pharmaceuticals Inc. Reports Operating Results (10-Q)

    GuruFocus

  7. Stocks Tumble On Disappointing Earnings Reports

    Investors Business Daily

  8. Stocks Hit Fresh Intraday Lows; Google Reverses Lower

    Investors Business Daily

  9. IBD 50: Cubist Pharma Earnings Beat Expectations

    Investors Business Daily

  10. Stocks Headed For Weaker Start; Polaris Motors Up

    Investors Business Daily

  11. Stocks Mixed In Afternoon Trade; Homebuilders Lead

    Investors Business Daily

  12. Stocks Extend Gains; American Tower Tests New High

    Investors Business Daily

  13. UPDATE: Morgan Stanley Initiates Cubist Pharmaceuticals at ...

    Benzinga

  14. Cubist Pharmaceuticals Inc. (CBST) SVP & CFO David W J Mcgirr ...

    GuruFocus

  15. Biogen, Cubist and Alexion Not The Only Biomed Leaders

    Investors Business Daily

  16. IBD 50: Questcor Shares Up On Acthar August Sales

    Investors Business Daily

  17. Cubist Pharmaceuticals Inc. (CBST) SVP & CFO David W J Mcgirr ...

    GuruFocus

  18. Cubist Pharmaceuticals Inc. (CBST) President & COO Robert J Perez ...

    GuruFocus

  19. Some IBD 50 Stocks Break Out As The Market Pauses

    Investors Business Daily

  20. Kraft Foods, Sherwin-Williams, Other Stocks Hit 52-Week Highs Friday

    FOXBusiness

  21. Cubist Has Long-Term Plan Growth

    Investors Business Daily

  22. Biotechs: Basing, With Possible Leaders On Deck

    Investors Business Daily

  23. Cubist Pharmaceuticals Inc. Reports Operating Results (10-Q)

    GuruFocus

  24. Biotechs In Motion As New Drug Pipeline Brims

    Investors Business Daily

  25. UPDATE: Jefferies Reiterates Buy Rating, Raises PT on Cubist ...

    Benzinga

  26. Meds Mixed In Late Earnings

    Investors Business Daily

  27. Intuitive Surgical, Athenahealth, Align Fall On Results

    Investors Business Daily

  28. Cubist Pharmaceuticals 2Q Results: Postgame Scorecard

    FOXBusiness

  29. Dendreon, Pharmacyclics and Other Biotech Takeover Targets

    Benzinga

  30. Small-Cap Corner: A Forgotten Biotech ETF

    Benzinga

  31. Medical Sector Shows Muscle With SXC Health, Cerner

    Investors Business Daily

  32. Arena Pharma Stock On Tear Ahead Of Diet Pill Review

    Investors Business Daily

  33. Arena Up Tue. In Pharma Rally Before Diet Pill Review

    Investors Business Daily

  34. Arena Leads Biopharma Rally As FDA Reviews Diet Pills

    Investors Business Daily

  35. Arena Leads Biopharma Rally As FDA Reviews Diet Pills

    Investors Business Daily

  36. At Cubist, Highly Engaged Workers Keep Experimenting

    Investors Business Daily

  37. The Definitive Biotech ETF Guide (IBB, XBI, FBT)

    Benzinga

  38. Medical Stocks Forming Bases Amid Market Sell-Off

    Investors Business Daily

  39. GlaxoSmithKline, Vertex Point To Biotech Strength

    Investors Business Daily

  40. Cubist Earnings Narrowly Exceed Expectations

    at IBD

  41. Questcor, Medical Firms Keep Small Cap Leaders Healthy

    at IBD

  42. IBD Tech Stock Screen: 5 Top Meds Start With Questcor

    at IBD

  43. IBD's Small-Cap Leaders Have Big Growth Potential

    at IBD

  44. Cubist Pharmaceuticals Inc. Reports Operating Results (10-K)

    at GuruFocus

  45. Cubist Pharmaceuticals Inc. (CBST) SVP & CFO David W J Mcgirr ...

    at GuruFocus

  46. Small Cap Screen: Buffalo Wild, Stone Energy Lead

    at IBD

  47. Gilead Sciences, Alexion Lead Surge In Biotech Stocks

    at IBD

  48. Top 5 Small-Cap Drug Firms Include Questcor, Cubist

    at IBD

  49. Wedbush Raises PT on Cubist Pharmaceuticals to $55

    at Benzinga

  50. Cubist Pharmaceuticals Inc. (CBST) EVP, COO Robert J Perez sells ...

    at GuruFocus

  51. Cubist Pharmaceuticals Inc. (CBST) EVP, COO Robert J Perez sells ...

    at GuruFocus

  52. Bank of America Reiterates Buy Rating on Cubist

    at Benzinga

  53. Cubist Pharmaceuticals Inc. (CBST) President and CEO Michael W ...

    at GuruFocus

  54. Cubist Pharmaceuticals Inc. (CBST) EVP, COO Robert J Perez sells ...

    at GuruFocus

  55. 5 Pharmaceutical Stocks to Buy, 1 to Avoid

    at GuruFocus

  56. RBC, Baird, and Jefferies lifted their targets for CBST

    By SchaeffersResearch
People viewing CBST also viewed: , , , , , ,
Marketplace
Trading Center